ROSEDEAN SURGERY
8 DEAN STREET, LISKEARD
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 10 | 14 | 71.4% | |
| HF 4 | 2011 | 15 | 19 | 78.9% | |
| HF 4 | 2012 | 14 | 22 | 63.6% | |
| HF 4 | 2013 | 10 | 14 | 71.4% | |
| HF004 | 2014 | 4 | 4 | 100.0% | |
| HF004 | 2015 | 4 | 5 | 80.0% | |
| HF004 | 2016 | 4 | 5 | 80.0% | |
| HF004 | 2017 | 4 | 5 | 80.0% | |
| HF004 | 2018 | 4 | 4 | 100.0% | |
| HF004 | 2020 | 7 | 7 | 100.0% | |
| HF006 | 2021 | 44 | 55 | 80.0% | |
| HF006 | 2022 | 44 | 47 | 93.6% | |
| HF006 | 2023 | 71 | 77 | 92.2% |
